1. Home
  2. GLRE vs DMII Comparison

GLRE vs DMII Comparison

Compare GLRE & DMII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Greenlight Capital Re Ltd.

GLRE

Greenlight Capital Re Ltd.

HOLD

Current Price

$15.48

Market Cap

554.9M

Sector

Finance

ML Signal

HOLD

DMII

Drugs Made In America Acquisition II Corp. Ordinary Shares

N/A

Current Price

$10.15

Market Cap

641.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
GLRE
DMII
Founded
2004
2024
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Blank Checks
Sector
Finance
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
554.9M
641.5M
IPO Year
2007
2025

Fundamental Metrics

Financial Performance
Metric
GLRE
DMII
Price
$15.48
$10.15
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
130.1K
55.0K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
75.00
N/A
EPS
0.18
N/A
Revenue
$729,777,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$86.22
N/A
Revenue Growth
4.85
N/A
52 Week Low
$11.57
$9.87
52 Week High
$19.39
$10.20

Technical Indicators

Market Signals
Indicator
GLRE
DMII
Relative Strength Index (RSI) 42.33 80.92
Support Level $14.57 $10.06
Resistance Level $17.05 N/A
Average True Range (ATR) 0.37 0.01
MACD -0.01 0.01
Stochastic Oscillator 24.55 100.00

Price Performance

Historical Comparison
GLRE
DMII

About GLRE Greenlight Capital Re Ltd.

Greenlight Capital Re Ltd offers property and casualty reinsurance. Its customers are property and casualty insurers, and Greenlight takes on some of their risk in exchange for insurance premiums. It operates through one operating segment: property and casualty reinsurance. It generates revenue through premiums from reinsurance on property and casualty business assumed and income from investments.

About DMII Drugs Made In America Acquisition II Corp. Ordinary Shares

Drugs Made In America Acquisition II Corp is a blank check Company.

Share on Social Networks: